Randomized Controlled Trial of Remote Foot Temperature Monitoring

Sponsor
VA Office of Research and Development (U.S. Fed)
Overall Status
Not yet recruiting
CT.gov ID
NCT05728411
Collaborator
(none)
800
3
2
105.4
266.7
2.5

Study Details

Study Description

Brief Summary

Diabetic foot ulcers are common, debilitating, and costly complications of diabetes, disproportionately impacting Black and rural Veterans. Forty percent of individuals have an ulcer recurrence within a year of ulcer healing and 65% within 5 years. Monitoring plantar foot temperatures is one of the few interventions that reduces the risk of ulcer recurrence. Despite the evidence, adoption has been poor because the original procedures, including the use of handheld thermometers, were burdensome and time-consuming. Podimetrics, a private company, has developed a temperature monitoring system involving a "smart" mat that can wirelessly transmit data and a remote monitoring team that works with VA providers to assist with triage and monitoring. This care model has incredible promise, but has been untested in VA. The investigators propose to conduct a randomized trial to evaluate effectiveness of remote temperature monitoring as well as costs. Additionally, the investigators will evaluate the implementation process, including barriers and facilitators to use among key stakeholders.

Condition or Disease Intervention/Treatment Phase
  • Other: Remote foot temperature monitoring system
  • Other: Enhanced usual care
N/A

Detailed Description

Objective(s) and Hypotheses: Diabetic foot ulcers (DFU) are common, debilitating, and costly complications of diabetes, disproportionately impacting Black and rural Veterans. Forty percent of individuals have an ulcer recurrence within a year of ulcer healing and 65% within 5 years. Remote temperature monitoring (RTM) of feet is one of the few interventions that reduces the risk of ulcer recurrence. Despite the evidence, adoption has been poor because the original procedures, including the use of handheld thermometers, were burdensome and time-consuming. Podimetrics, a private company, has developed a temperature monitoring system involving a "smart" mat that measure foot temperatures and a remote monitoring team that works with VA providers to assist with triage and monitoring. This care model has incredible promise, but has been untested in VA.

The specific aims of this study are to: 1) Evaluate the effectiveness of RTM vs. usual care in terms of primary (ulceration) and secondary outcomes (severity of ulceration, amputation, hospitalization, emergency room visits, quality of life, satisfaction with care, and patient activation) at 6, 12, 18, and 24 months; 2) Collect data on costs of RTM and compare with usual care costs, if effectiveness is demonstrated; and 3) Evaluate the implementation process, including barriers and facilitators to use among key stakeholders

Research Design: For Aim 1, the investigators will conduct a 3-site randomized controlled study. Aim 2 involves a budget impact analysis to evaluate costs of RTM. Aim 3 involves qualitative interviews to understand barriers and facilitators to implementation of RTM.

Methodology: For Aim 1, the investigators will aim to enroll at least 406 patients who have had a DFU or amputation within the past 24 months (including active ulcers). Patients will be randomized 1:1 to RTM or usual care (no RTM), with randomization stratified on site and active ulcer vs. not. For Aim 2, the investigators will collect data and observe providers to quantify provider time for selecting patients for RTM, ordering mats, and responding to alerts of "hot spots". The investigators will use medical records to assess patient utilization (ulcer/amputation-related outpatient, inpatient, and emergency room visits) and associated costs of care for patients in the RTM and comparison groups. For Aim 3, the investigators will conduct semi-structured phone interviews with 30-50 Veterans and 6-12 providers and use the Consolidated Framework for Implementation Research to guide data collection and analysis.

Relevance to VA Mission: Findings from this study will be used to inform effective, efficient, and equitable scaling of RTM in VA.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
800 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Health Services Research
Official Title:
Home Foot-Temperature Monitoring Through Smart Mat Technology to Improve Access, Equity, and Outcomes in High-Risk Patients With Diabetes
Anticipated Study Start Date :
Mar 20, 2023
Anticipated Primary Completion Date :
Dec 31, 2026
Anticipated Study Completion Date :
Dec 31, 2031

Arms and Interventions

Arm Intervention/Treatment
Experimental: Remote temperature monitoring + enhanced usual care

Enrollment in remote foot temperature monitoring in addition to enhanced usual care (described below)

Other: Remote foot temperature monitoring system
Remote temperature monitoring involves a thermometric mat that can detect "hot spots" on the plantar surface of the foot. The mat has embedded cellular connectivity so that data can be transmitted from the patient's home to the company, where the temperature data can be analyzed. The company has a team of health coaches that work with patients and providers to detect signs of damage early in order to prevent ulceration.

Other: Enhanced usual care
Usual care is based on the VA's amputation prevention program (PAVE - Preventing Amputation in Veterans Everywhere - VHA Directive 1410), which provides a model of care for patients at risk for amputation as well as patients who have already undergone an amputation. Usual care will be enhanced by providing resources (e.g., information through written newsletters) relevant to a population of Veterans with diabetes, including information on nutrition and cooking, physical activities, and whole health opportunities

Other: Enhanced usual care

Usual care is based on the VA's amputation prevention program (PAVE - Preventing Amputation in Veterans Everywhere - VHA Directive 1410), which provides a model of care for patients at risk for amputation as well as patients who have already undergone an amputation. Usual care will be enhanced by providing resources (e.g., information through written newsletters) relevant to a population of Veterans with diabetes, including information on nutrition and cooking, physical activities, and Whole Health opportunities

Other: Enhanced usual care
Usual care is based on the VA's amputation prevention program (PAVE - Preventing Amputation in Veterans Everywhere - VHA Directive 1410), which provides a model of care for patients at risk for amputation as well as patients who have already undergone an amputation. Usual care will be enhanced by providing resources (e.g., information through written newsletters) relevant to a population of Veterans with diabetes, including information on nutrition and cooking, physical activities, and whole health opportunities

Outcome Measures

Primary Outcome Measures

  1. Foot ulceration [24 months]

    The primary outcome is the presence of new ulceration through 24 months

Secondary Outcome Measures

  1. Lower limb amputation [24 months]

    Any level of lower extremity amputation

  2. Quality of life [6,12, 18 and 24 months]

    PROMIS Global Health 1.2

  3. Satisfaction with care [6,12, 18 and 24 months]

    Short assessment of patient satisfaction (SAPS) Hawthorne G et al

  4. Patient activation [6, 12, 18, and 24 months]

    10-item Patient activation measure by Skolasky et al

Other Outcome Measures

  1. Utilization (outpatient visits, emergency room visits, hospitalizations) [6, 12, 18, and 24 months]

    Based on electronic medical record data

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 89 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Veteran

  • Diabetes diagnosis

  • Presence of foot ulcer up to 24 months prior (including active ulcer)

  • Lower extremity amputation up to 24 months prior (including unhealed amputation)

  • Able to understand/read English

Exclusion Criteria:
  • Dementia

  • Unable to ambulate

  • Bilateral lower extremity amputation

  • Ankle brachial index <0.6

  • Life expectancy less than 18 months

  • Currently using in-home temperature monitoring

  • Prisoner

Contacts and Locations

Locations

Site City State Country Postal Code
1 Edward Hines Jr. VA Hospital, Hines, IL Hines Illinois United States 60141-3030
2 Hunter Holmes McGuire VA Medical Center, Richmond, VA Richmond Virginia United States 23249
3 VA Puget Sound Health Care System Seattle Division, Seattle, WA Seattle Washington United States 98108-1532

Sponsors and Collaborators

  • VA Office of Research and Development

Investigators

  • Principal Investigator: Alyson J. Littman, PhD MPH, VA Puget Sound Health Care System Seattle Division, Seattle, WA

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
VA Office of Research and Development
ClinicalTrials.gov Identifier:
NCT05728411
Other Study ID Numbers:
  • IIR 21-176
First Posted:
Feb 15, 2023
Last Update Posted:
Feb 15, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by VA Office of Research and Development
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 15, 2023